Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.
about
Dried-Plasma Transport Using a Novel Matrix and Collection System for Human Immunodeficiency Virus and Hepatitis C Virus Virologic TestingOptimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settingsMonitoring HIV viral load in resource limited settings: still a matter of debate?Pyrosequencing dried blood spots reveals differences in HIV drug resistance between treatment naïve and experienced patientsEvaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoringStability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance GenotypingDual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR.Transmitted drug resistance in nonsubtype B HIV-1 infection.Field study of dried blood spot specimens for HIV-1 drug resistance genotypingDevelopment and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance.Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infectionHIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping SystemAntiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settingsHIV type 1 mutational patterns in HIV type 1 subtype C-infected long-term survivors in Karonga District Malawi: further analysis and correction.Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.Correlation of serum and dried blood spot results for quantitation of Schistosoma circulating anodic antigen: a proof of principleUse of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican PatientsField evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees CNevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperatureEvaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testingRapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes.Dried blood spots in HIV monitoring: applications in resource-limited settings.Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis.Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistanceDried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal.HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.Detection of low levels of human immunodeficiency virus (HIV) may be critical for early diagnosis of pediatric HIV infection by use of dried blood spotsHigh Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia.Dried Blood Spots for Use in HIV-Related Epidemiological Studies in Resource-Limited Settings
P2860
Q27488389-9674D026-0CD6-4E7B-BF7F-2EF1D2A40504Q28478154-010555F2-A07D-4C85-9D0C-0D8B321B92BFQ28485511-521BB21F-D557-433A-B8E5-0DAA922CE5BFQ28486033-01D63D5B-00CE-4EF8-BD03-62F61B958844Q28543688-714F6085-00CC-441F-8136-711479DDC1DAQ28546274-4B2D2176-602F-432F-9A22-AC1EBE1B5F45Q30389401-95FE70DE-F8A0-45D5-9568-119E4089C4FBQ33463338-42855665-5DB7-484E-98A0-DE54BE2B3F99Q33567164-51387D86-E6E3-4174-BEBB-041D33C1D6DAQ34058841-CF525DF3-ACE8-424B-9859-F16AFCC708E2Q34120410-62959B43-55FF-4E8A-A020-068325224026Q34214893-289FB6A8-E54C-450A-8892-895FC18FAB11Q34481348-C28FE6A6-E273-4535-B857-FFCB8B716C82Q34745289-AD88E230-31CF-4473-8B49-33DA0B40496BQ35598943-6D7B2FC6-6CA4-4F55-84D0-DF8F264ECA59Q35799135-1ED44F55-B904-4B10-9095-F8C72176F3EDQ35917540-CFF84558-6D42-4D34-845F-ED1100A99BA5Q36098805-63829B57-728E-46F9-9D43-C26FCF08B1C2Q36119307-B7FB8A27-050F-40EF-921D-C85B4DD32E1BQ36392010-F3D4C253-5647-4C56-8415-D55E1B72741AQ36558961-648C321C-E40E-485B-AFE0-ACBC4DAD08BDQ36660627-B2710BAD-C7AA-46CF-97DC-13C31FFB9384Q37156827-59DA0D5B-558A-4D70-8A71-8F21420D363DQ37156947-878C832B-8481-4A31-92AA-052EE55750E5Q37217095-CA660E89-9036-49E1-B53D-F7585BE77637Q37395749-D87D787E-8B95-4C17-8AD1-1084E3ABCA68Q37810287-3AE1565B-8BAE-4AD5-9CEA-E4A6D10752F5Q37885461-8D6D80C6-5F46-4217-BFC5-C4F124327CF6Q40796505-4E5736E1-7854-4848-90C9-EAFA56CACF7AQ41868619-837CD6BD-2555-4441-8469-F5FD528C4C8DQ42262687-D80F89A2-B112-482F-8A40-B94A614E43D2Q42263579-D084BCD6-6501-4DF8-B509-FFABBD414916Q42546213-901F0B0A-AC5B-4F36-BF9B-927B68D2993CQ47547186-E0100164-39E2-4DA7-B17E-23650F934186Q58488463-A3BE5DF1-3D82-448D-AE0F-4C8D69797E36
P2860
Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@ast
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@en
type
label
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@ast
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@en
prefLabel
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@ast
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@en
P2093
P2860
P356
P1476
Evaluation of dried blood spot ...... ype 1 drug resistance testing.
@en
P2093
Amanda McNulty
Cheryl Jennings
Diane Bennett
J Gerardo García-Lerma
James W Bremer
Joseph Fitzgibbon
Marcia L Kalish
Michael Ussery
P2860
P304
P356
10.1128/JCM.02016-06
P407
P577
2006-12-13T00:00:00Z